Site assessment and audits

Aepodia is experienced in evaluating Phase I units, hospital-based investigational sites, and different vendors involved in clinical trials. Our evaluations are performed by qualified auditors in accordance with EMA INS-GCP-3 Annex 3 and MHRA Accreditation Standards and country-specific regulations. Aepodia auditors evaluate Phase 1 trial-related vendors in accordance with relevant GCP, GMP, GLP, and Computer System Validation requirements. Audit reports are shared with clients as well as any corrective action plans and follow-up.